Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients

Conclusions:
Our results suggest that propranolol could reduce the growth of HIF-dependent tumors and may thus be a promising treatment to delay surgery in VHL patients.

Source: Orphanet Journal of Rare Diseases - September 22, 2015 Category: Internal Medicine Authors: Virginia AlbiñanaKarina Villar Gómez de las HerasGemma Serrano-HerasTomás SeguraAna Perona-MoratallaMercedes Mota-PérezJosé de CamposLuisa Botella Source Type: research